Chlamydia pneumoniae infections and development of lung cancer: systematic review
- PMID: 35317845
- PMCID: PMC8941765
- DOI: 10.1186/s13027-022-00425-3
Chlamydia pneumoniae infections and development of lung cancer: systematic review
Abstract
Background: Chlamydia pneumoniae is an obligate intracellular pathogen and is a common cause of human respiratory diseases, including pneumonia. It has been already known to have a causal relationship with some chronic diseases such as chronic obstructive pulmonary disease, asthma, and atherosclerotic cardiovascular diseases. In this review, we aim to find out the association between C. pneumoniae infection and lung cancer.
Methods: This is a systematic review on C. pneumoniae infection and the development of lung cancer, based on published articles consolidated from PubMed and Google Scholar on the topic.
Results: Out of 46 articles, 27 were selected and screened through the process. Twenty-four articles positively supported the hypothesis with one animal model, while 3 of them were negatively supportive. Several proposed mechanisms explain the pathogenesis with some knowledge gaps.
Conclusion: Although some studies showed an association between C. pneumoniae infection and lung cancer, whether the C. pneumoniae infection is an individual risk factor for lung cancer is still debatable. And it needs further experimental studies on both humans and animals with large observational studies to better understand the association between C. pneumoniae infection and lung cancer.
Keywords: Chlamydia pneumoniae; Lung cancer; Risk factor; Serology.
© 2022. The Author(s).
Conflict of interest statement
The authors declare that they have no competing interests.
References
-
- Kuo CC, Jackson LA, Campbell LA, Grayston JT. Chlamydia pneumoniae (TWAR) Clinical Microbiology Reviews. American Society for Microbiology; 1995 [cited 2021 Jun 21]. p. 451–61. https://journals.asm.org/journal/cmr - PMC - PubMed
-
- E. P. Is Chlamydophila pneumoniae an etiological agent of non-infectious diseases? Vol. 44, Postepy Mikrobiologii. 2005.
-
- Chlamydia pneumoniae Infection and Inflammatory Diseases [Internet]. [cited 2021 Jun 21]. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6345537/
-
- Shen M, Cai L, Jiang K, Xu W, Chen Y, Xu Z. The therapeutic role of inhibition of miR-328 on pulmonary carcinoma induced by chlamydia pneumoniae through targeting histone H2AX. Cancer Biomarkers. 2019; - PubMed
Publication types
LinkOut - more resources
Full Text Sources